Strong Q4 Bookings Momentum
Q4 bookings totaled $11.3 million versus $8.2 million in the prior-year period (up ~37%), driven by strong renewals and broad-based demand across healthcare, financial services and consumer clients.
Record High Average Bill Rate
Achieved an all-time high average bill rate of $87.32 in Q4, reflecting disciplined pricing and a shift to higher-value, higher-margin staffing engagements.
Solid Liquidity and No Debt
Cash balance of $36.5 million as of 12/31/2025, no bank debt outstanding and $19.9 million available under the revolving credit facility; DSO at 54 days (in target range).
Share Repurchase Activity and Authorization
Repurchased ~$0.7 million in Q4 and ~$2.2 million for the full year (avg prices $7.20 and $7.49). Board authorized a new repurchase program up to $5 million effective Feb 16, 2026.
Non-GAAP Profitability Stability
Full-year non-GAAP net income of $8.6 million ($0.72 per diluted share) was flat year-over-year, and Q4 non-GAAP net income was $2.5 million ($0.21 per diluted share) vs $2.8 million prior-year, showing resilient underlying profitability after adjustments.
Gross Margins Stabilized for the Year
Full-year gross margins remained essentially flat year-over-year despite revenue declines, indicating margin discipline and cost management progress under the EDGE program.
Operational and Strategic Progress (EDGE and AI Focus)
EDGE initiative delivered efficiencies and freed capacity for reinvestment; advanced data-platform partnerships (GCP, Snowflake, Informatica) and established an industry solutions practice focused on AI-powered workflows to position the company for AI-led growth in 2026.
Improved Q4 GAAP Net Income versus Prior Year Quarter
Q4 GAAP net income of $1.0 million ($0.08 per diluted share) compared with $0.3 million ($0.02) in the prior-year quarter, aided by lower one-time costs in Q4.